Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

46.4K
Overview
46.4K
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

341
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
341
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

681
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
681
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

260
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
260

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Organoids to Model Tumor Microenvironment in Progression of Pathogenesis and Treatment Resistance in Glioblastoma Multiforme.

Brain sciences·2026
Same author

Exosome Engineering for Blocking Gut Dysbiosis and Inducing Cell Death Mechanisms in Glioblastoma Multiforme.

Cells·2026
Same author

Focal Estrogen Therapy in Male Rats Promotes Neuronal Survival and Reduces Denervation Atrophy After Spinal Cord Injury via Modulation of β-Catenin and NF-κB.

Neurochemical research·2026
Same author

Exosomes as Specific Vehicles for Delivery of Combination Therapies for Inhibiting Autophagy and Inducing Apoptosis in MYCN-Amplified Neuroblastoma Displaying Gut Dysbiosis: Current Challenges and Future Opportunities.

Brain sciences·2026
Same author

Controlling Biogenesis and Engineering of Exosomes to Inhibit Growth and Promote Death in Glioblastoma Multiforme.

Brain sciences·2026
Same author

'Molecular and Cellular Neuroscience': Impacts of Eight Highly Cited Articles Published in This Section of <i>Brain Sciences</i> in 2024.

Brain sciences·2026
Same journal

Adenosine kinase is a new therapeutic target to prevent ischemic neuronal death.

The open drug discovery journal·2013
Same journal

Targeting Dopamine in Acute Traumatic Brain Injury.

The open drug discovery journal·2012
Same journal

The Protective Effects of Ischemic Postconditioning against Stroke: From Rapid to Delayed and Remote Postconditioning.

The open drug discovery journal·2011
Same journal

Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

The open drug discovery journal·2011
See all related articles

Related Experiment Video

Updated: May 16, 2025

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
04:02

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy

Published on: November 29, 2024

948

Neuroprotective Drugs in Traumatic CNS Injury.

Supriti Samantaray1, Nakul P Thakore1, Denise D Matzelle1

  • 1Division of Neurology, Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA.

The Open Drug Discovery Journal
|April 4, 2025
PubMed
Summary
This summary is machine-generated.

Developing neuroprotective drugs for traumatic central nervous system (CNS) injuries remains challenging. This review explores promising therapeutic agents, including estrogen and melatonin, for CNS injury treatment.

Keywords:
Neuroprotective agentsestrogenmelatoninspinal cord injury

More Related Videos

Controlled Cortical Impact Model for Traumatic Brain Injury
05:30

Controlled Cortical Impact Model for Traumatic Brain Injury

Published on: August 5, 2014

28.5K
Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging
11:14

Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging

Published on: April 6, 2014

12.4K

Related Experiment Videos

Last Updated: May 16, 2025

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
04:02

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy

Published on: November 29, 2024

948
Controlled Cortical Impact Model for Traumatic Brain Injury
05:30

Controlled Cortical Impact Model for Traumatic Brain Injury

Published on: August 5, 2014

28.5K
Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging
11:14

Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging

Published on: April 6, 2014

12.4K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Traumatology

Background:

  • Traumatic central nervous system (CNS) injuries affect young adults, with limited effective treatments.
  • Existing neuroprotective drugs show modest clinical benefits.
  • Research is ongoing to identify and validate novel therapeutic strategies.

Purpose of the Study:

  • To review promising neuroprotective drugs for traumatic CNS injuries.
  • To consolidate updates on experimental and clinical findings.
  • To highlight the potential of endogenous molecules like estrogen and melatonin.

Main Methods:

  • Literature review of experimental and clinical studies on neuroprotective agents.
  • Focus on drugs tested for traumatic CNS injuries.
  • Specific investigation of estrogen and melatonin in experimental spinal cord injury models.

Main Results:

  • Few neuroprotective drugs have demonstrated significant efficacy in clinical trials.
  • Some neuroprotective molecules show promise in experimental settings.
  • Estrogen and melatonin are under investigation for their therapeutic potential.

Conclusions:

  • There is a critical need for effective neuroprotective therapies for CNS injuries.
  • Estrogen and melatonin represent promising candidates for future clinical development.
  • Further research is warranted to establish the efficacy and safety of these agents.